Directory
>
Archana Belle
Archana Belle
Vice President, Translational Research | Encoded Therapeutics Inc.
San Francisco, California, United States
Archana Belle
Summary
Archana Belle is a seasoned leader in translational research with over 20 years of experience in advancing innovative therapeutics for central nervous system disorders. As the Vice President at Encoded Therapeutics, she has been pivotal in the development of gene therapies, showcasing her expertise in protein and molecular sciences, immunology, and biochemistry. Archana has a proven track record of building high-performing teams and fostering collaborations that enhance drug development processes. Her contributions have led to successful regulatory filings, facilitating the transition of groundbreaking therapies into clinical stages. With a strong academic foundation, including a Ph.D. in Molecular Genetics, she has also published extensively in high-impact journals. Archana thrives in dynamic, data-driven environments and is passionate about mentoring the next generation of scientists in the field.
Archana Belle
Work Experience
Vice President, Translational Research at
Encoded Therapeutics Inc.
June 2021 - Present
Senior Director, Translational Research at
Encoded Therapeutics Inc.
September 2019 - June 2021
Director, Translational Research at
Encoded Therapeutics Inc.
April 2018 - August 2019
Associate Director, Bioanalytics at
Astellas Gene Therapies
January 2017 - March 2018
Senior Bioanalytical Scientist at
Audentes Therapeutics
November 2015 - December 2016
Principal Scientist and Group Leader at
Planet Biotechnology, Inc.
December 2011 - October 2015
Senior Scientist at
Planet Biotechnology, Inc.
July 2006 - December 2011
Post-doctoral fellow at
Ucsf Department Of Biophysics And Biochemistry
January 2001 - December 2005
Archana Belle
Education
State University of New York - Albany, Ph.D. Molecular Genetics
January 1994 - January 2000
Hindu College, University of Delhi , B.Sc.
m.s. university, baroda, M.Sc.
Frequently Asked Questions about Archana Belle
What is Archana Belle email address?
Archana Belle's primary email address is *******@encodedgenomics.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Archana Belle work for?
Archana Belle is a Vice President, Translational Research at Encoded Therapeutics Inc., a company specializing in Commercial physical research.
Where Archana Belle graduated from?
Archana Belle holds a degree in Advisor: David Shub And Marlene Belfort from State University of New York - Albany.
How can I directly contact Archana Belle?
To contact Archana Belle directly, you can use the email address *******@encodedgenomics.com. Complete contact information is available upon registration with Muraena.
Who is Archana Belle?
Archana Belle is a seasoned leader in translational research with over 20 years of experience in advancing innovative therapeutics for central nervous system disorders. As the Vice President at Encoded Therapeutics, she has been pivotal in the development of gene therapies, showcasing her expertise in protein and molecular sciences, immunology, and biochemistry. Archana has a proven track record of building high-performing teams and fostering collaborations that enhance drug development processes. Her contributions have led to successful regulatory filings, facilitating the transition of groundbreaking therapies into clinical stages. With a strong academic foundation, including a Ph.D. in Molecular Genetics, she has also published extensively in high-impact journals. Archana thrives in dynamic, data-driven environments and is passionate about mentoring the next generation of scientists in the field.
Archana`s contact details
*******@encodedgenomics.com
*******@encoded.com
Colleagues
Chief Medical Officer
Chief Manufacturing Officer
Scientific Advisor
Co-Founder and Chief Scientific Officer
Vice President, Clinical Operations
Vice President, Engineering
Board Member
Investor
General Counsel, Chief Compliance Officer & Corporate Secretary
Vice President of MSAT and Manufacturing